Day: April 15, 2024

Fresenius Accelerates Momentum in its (Bio)Pharma Business and Launches Tyenne®, its Third Approved Biosimilar in the U.S.

Tyenne® is the first tocilizumab biosimilar by Fresenius Kabi, an operating company of Fresenius SE, with an intravenous and subcutaneous...

Netsmart Launches the Netsmart Marketplace Advancing Interoperability and Integration Offerings for Community-Based Care Providers

OVERLAND PARK, Kan.--(BUSINESS WIRE)--#EHR--Netsmart, an industry-leading provider of healthcare technology solutions and services for community-based providers, unveils the Netsmart Marketplace....

FSD Pharma Provides Update on its Investment in Celly Nutrition Corp., a Company Launching a Product that can assist in Expediting Alcohol Metabolism and Faster Recovery from Alcohol Consumption

error: Content is protected !!